In parallel, JunB could bind to the unmethylated promoter of CD30 through the AP-1 site in ALCL, thereby contributing to high expression of CD30 (Watanabe et al., 2005; Watanabe et al., 2008). Here, JUN is linked to anaplastic large cell lymphoma.